S

Sarepta Therapeutics
D

SRPT

118.970
USD
-0.47
(-0.39%)
Market Closed
Volume
46,523
EPS
2
Div Yield
-
P/E
77
Market Cap
11,363,972,761
Related Instruments
    BIIB
    BIIB
    -0.780
    (-0.53%)
    146.590 USD
    B
    BLUE
    -0.69000
    (-7.52%)
    8.49000 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    I
    IONS
    0.040
    (0.11%)
    35.630 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    R
    RGLS
    0.04000
    (2.58%)
    1.59000 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: Sarepta Therapeutics

Sector: Healthcare
Industry: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.